A New Prognostic Scoring System (BRIGHT) Predicts Mortality of Septic Shock after Allogeneic Hematopoietic Stem Cell Transplantation

Tian-xiao Han,Hai-xia Fu,Han Meng,Qiu-sha Huang,Peng Zhao,Ye-jun Wu,Yun He,Xiao-lu Zhu,Feng-rong Wang,Yuan-yuan Zhang,Xiao-dong Mo,Wei Han,Chen-hua Yan,Jing-zhi Wang,Huan Chen,Yu-hong Chen,Ting-ting Han,Meng Lv,Yao Chen,Yu Wang,Lan-ping Xu,Kai-yan Liu,Xiao-Jun Huang,Xiao-Hui Zhang
DOI: https://doi.org/10.2139/ssrn.3973434
2021-01-01
SSRN Electronic Journal
Abstract:Background: Septic shock remains a potentially fatal complication among allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. To date, no information is available on predicting outcomes of such patients. Therefore, establishing a scoring system to guide targeted therapy is essential. We aimed to develop and validate a prognostic model for predicting short-term mortality in allo-HSCT recipients with septic shock. Methods: We retrospectively studied 278 septic shock patients from 6105 consecutive patients allografted between 2007 and 2020 in our center. They were divided into a derivation cohort and an external validation cohort by transplantation time. Demographic, clinical, laboratory and pathogen-related information were collected from electronic medical records. Univariate and multivariate logistic regression models were used to identify predictors of early mortality. A prognostic model for septic shock was derived in the derivation cohort and validated both internally and externally.Findings: Five independent predictors were identified by multivariate logistic analysis: serum bilirubin (OR 1.013, 95%CI 1.004-1.023, p = 0.007), interval between HSCT and septic shock (8.901, 3.374-23.485, p < 0.001) , GFR (0.983, 0.972-0.994, p = 0.003), hemorrhage events (9.248, 3.341-25.601, p < 0.001) , and HCT-CI (1.520, 1.065-2.168, p = 0.021), which composed our scoring system termed BRIGHT. Both in internal and external validation, our model exhibited excellent performance. Interpretation: Our findings indicate that an effective prognostic scoring system can help predict early death in allo-HSCT recipients after septic shock. The model will contribute to more precise clinical care. Funding: Key Program of National Natural Science Foundation of China (No. 81730004)Declaration of Interest: We declare that we have no conflicts of interestEthical Approval: The study protocol was approved by the central institutional review board of the Peking University People’s Hospital, Beijing, China.
What problem does this paper attempt to address?